Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Joshua Adam Barocas

TitleAssociate Professor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED

    Collapse Research 
    Collapse research activities and funding
    R01DA061228     (BAROCAS, JOSHUA ADAM)Sep 1, 2024 - May 31, 2029
    NIH
    improving Health and Housing Outcomes through a Simulation and Economic Model (iHOUSE Model)
    Role: Principal Investigator
    R01DA058352     (TOOKES, HANSEL EMORY)Jun 1, 2023 - Mar 31, 2028
    NIH
    In pursuit of a one-stop shop: a hybrid type 1 effectiveness-implementation trial of comprehensive tele-harm reduction for people who inject drugs
    Role: Co-Principal Investigator
    DP2DA051864     (BAROCAS, JOSHUA ADAM)Aug 1, 2020 - Jul 31, 2024
    NIH
    Development of a novel community-based high-performance surveillance network for drug use
    Role: Principal Investigator
    K01DA051684     (BAROCAS, JOSHUA ADAM)Jun 15, 2020 - May 31, 2025
    NIH
    Strategies to reduce serious bacterial infections and overdose among people who inject drugs
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Doogan NJ, Mack A, Wang J, Crane D, Jackson R, Applegate M, Villani J, Chandler R, Barocas JA. Correction to: Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method. Am J Epidemiol. 2023 Dec 19. PMID: 38140815.
      View in: PubMed
    2. Tin Y, Castry M, Bowers-Sword R, Shantharam S, Aldridge A, Zarkin GA, Starbird L, Linas BP, Barocas JA, Morgan JR. Establishing a Protocol for Determining the Costs of an Integrated Set of Evidence-based Practices Aimed at Reducing Opioid Overdose Deaths. J Addict Med. 2024 Jan-Feb 01; 18(1):13-18. PMID: 37768777.
      View in: PubMed
    3. Wang J, Doogan N, Thompson K, Bernson D, Feaster D, Villani J, Chandler R, White LF, Kline D, Barocas JA. Massachusetts Prevalence of Opioid Use Disorder Estimation Revisited: Comparing a Bayesian Approach to Standard Capture-Recapture Methods. Epidemiology. 2023 11 01; 34(6):841-849. PMID: 37757873.
      View in: PubMed
    4. Savinkina A, Jurecka C, Gonsalves G, Barocas JA. Mortality, incarceration and cost implications of fentanyl felonization laws: A modeling study. Int J Drug Policy. 2023 Nov; 121:104175. PMID: 37729682.
      View in: PubMed
    5. Flam-Ross JM, Marsh E, Weitz M, Savinkina A, Schackman BR, Wang J, Madushani RWMA, Morgan JR, Barocas JA, Walley AY, Chrysanthopoulou SA, Linas BP, Assoumou SA. Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder. JAMA Netw Open. 2023 09 05; 6(9):e2329583. PMID: 37703018.
      View in: PubMed
    6. Palis H, Barocas JA, Moe J, Scow M, Sedgemore KO, Slaunwhite AK, Buxton JA. Rising rates of infective endocarditis in North America: An urgent need for attention to the rapidly changing unregulated drug supply. Int J Drug Policy. 2023 08; 118:104110. PMID: 37390695.
      View in: PubMed
    7. Barocas JA, Nall SK, Axelrath S, Pladsen C, Boyer A, Kral AH, Meehan AA, Savinkina A, Peery D, Bien M, Agnew-Brune C, Goldshear J, Chiang J, Linas BP, Gonsalves G, Bluthenthal RN, Mosites E. Population-Level Health Effects of Involuntary Displacement of People Experiencing Unsheltered Homelessness Who Inject Drugs in US Cities. JAMA. 2023 05 02; 329(17):1478-1486. PMID: 37036716.
      View in: PubMed
    8. Jawa R, Tin Y, Nall S, Calcaterra SL, Savinkina A, Marks LR, Kimmel SD, Linas BP, Barocas JA. Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Netw Open. 2023 04 03; 6(4):e237888. PMID: 37043198.
      View in: PubMed
    9. Jurecka CA, Barocas JA. Using Evidence to Inform Legislation Aimed at Curbing Fentanyl Deaths. JAMA Health Forum. 2023 01 06; 4(1):e225202. PMID: 36705915.
      View in: PubMed
    10. Thompson K, Barocas JA, Delcher C, Bae J, Hammerslag L, Wang J, Chandler R, Villani J, Walsh S, Talbert J. The prevalence of opioid use disorder in Kentucky's counties: A two-year multi-sample capture-recapture analysis. Drug Alcohol Depend. 2023 01 01; 242:109710. PMID: 36469995.
      View in: PubMed
    11. Doogan NJ, Mack A, Wang J, Crane D, Jackson R, Applegate M, Villani J, Chandler R, Barocas JA. Opioid Use Disorder Among Ohio's Medicaid Population: Prevalence Estimates From 19 Counties Using a Multiplier Method. Am J Epidemiol. 2022 11 19; 191(12):2098-2108. PMID: 36004683.
      View in: PubMed
    12. Lazarus JV, Romero D, Kopka CJ, Karim SA, Abu-Raddad LJ, Almeida G, Baptista-Leite R, Barocas JA, Barreto ML, Bar-Yam Y, Bassat Q, Batista C, Bazilian M, Chiou ST, Del Rio C, Dore GJ, Gao GF, Gostin LO, Hellard M, Jimenez JL, Kang G, Lee N, Maticic M, McKee M, Nsanzimana S, Oliu-Barton M, Pradelski B, Pyzik O, Rabin K, Raina S, Rashid SF, Rathe M, Saenz R, Singh S, Trock-Hempler M, Villapol S, Yap P, Binagwaho A, Kamarulzaman A, El-Mohandes A. A multinational Delphi consensus to end the COVID-19 public health threat. Nature. 2022 Nov; 611(7935):332-345. PMID: 36329272.
      View in: PubMed
    13. Barocas JA, Strathdee SA. Beyond Sex: Human Monkeypox Virus is an Emerging Threat to Marginalized Populations. Open Forum Infect Dis. 2022 Nov; 9(11):ofac551. PMID: 36381615.
      View in: PubMed
    14. Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected Long-Term Impact of the Coronavirus Disease 2019 (COVID-19) Pandemic on Hepatitis C Outcomes in the United States: A Modeling Study. Clin Infect Dis. 2022 08 24; 75(1):e1112-e1119. PMID: 34499124.
      View in: PubMed
    15. Wheeler A, Valerio H, Cunningham EB, Martinello M, Barocas JA, Colledge-Frisby S, Treloar C, Amin J, Henderson C, Read P, Matthews GV, Dunlop AJ, Gorton C, Hayllar J, Alavi M, Murray C, Marks P, Silk D, Degenhardt L, Dore GJ, Grebely J. Prevalence and factors associated with hospitalisation for bacterial skin infections among people who inject drugs: The ETHOS Engage Study. Drug Alcohol Depend. 2022 08 01; 237:109543. PMID: 35772249.
      View in: PubMed
    16. Barocas JA, Gai MJ, Nurani A, Bagley SM, Hadland SE. Initiation of HIV pre-exposure prophylaxis among youth in the United States, 2015-2018. AIDS Care. 2023 03; 35(3):431-436. PMID: 35468009.
      View in: PubMed
    17. Bettano A, Del Pozo B, Bernson D, Barocas JA. Stimulant-related incident surveillance using emergency medical service records in Massachusetts, 2013-2020. Drug Alcohol Depend. 2022 06 01; 235:109460. PMID: 35468556.
      View in: PubMed
    18. Savinkina A, Madushani RWMA, Eftekhari Yazdi G, Wang J, Barocas JA, Morgan JR, Assoumou SA, Walley AY, Linas BP, Murphy SM. Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis. Addiction. 2022 09; 117(9):2450-2461. PMID: 35315162.
      View in: PubMed
    19. Keyes KM, Rutherford C, Hamilton A, Barocas JA, Gelberg KH, Mueller PP, Feaster DJ, El-Bassel N, Cerd? M. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size. Drug Alcohol Depend Rep. 2022 Jun; 3. PMID: 35783994.
      View in: PubMed
    20. Adams JW, Savinkina A, Fox A, Behrends CN, Madushani RWMA, Wang J, Chatterjee A, Walley AY, Barocas JA, Linas BP. Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs. Addiction. 2022 10; 117(10):2635-2648. PMID: 35315148.
      View in: PubMed
    21. Sinha P, Barocas JA. Cost-effectiveness of aducanumab to prevent Alzheimer's disease progression at current list price. Alzheimers Dement (N Y). 2022; 8(1):e12256. PMID: 35282659.
      View in: PubMed
    22. Adams JW, Savinkina A, Hudspeth JC, Gai MJ, Jawa R, Marks LR, Linas BP, Hill A, Flood J, Kimmel S, Barocas JA. Simulated Cost-effectiveness and Long-term Clinical Outcomes of Addiction Care and Antibiotic Therapy Strategies for Patients With Injection Drug Use-Associated Infective Endocarditis. JAMA Netw Open. 2022 Feb 01; 5(2):e220541. PMID: 35226078.
      View in: PubMed
    23. Zielinski MJ, Praseuth A, Gai MJ, Evans LJ, Zaller ND, Umar I, Barocas JA. Crisis stabilization units for jail diversion: A preliminary assessment of patient characteristics and outcomes. Psychol Serv. 2022 Nov; 19(4):630-636. PMID: 35099227.
      View in: PubMed
    24. Wurcel AG, Zubiago J, Reyes J, Smyth E, Balsara KR, Avila D, Barocas JA, Beckwith CG, Bui J, Chastain CA, Eaton EF, Kimmel S, Paras ML, Schranz AJ, Vyas DA, Rapoport A. Surgeons' Perspectives on Valve Surgery in People With Drug Use-Associated Infective Endocarditis. Ann Thorac Surg. 2023 09; 116(3):492-498. PMID: 35108502.
      View in: PubMed
    25. Rubin EJ, Baden LR, Barocas JA, Morrissey S. Audio Interview: Addressing the Omicron Variant of SARS-CoV-2. N Engl J Med. 2022 Jan 27; 386(4):e16. PMID: 35081288.
      View in: PubMed
    26. Barocas JA. 100-100-100: a new, ambitious treatment target to end the HIV and hepatitis C epidemics. Lancet Public Health. 2022 02; 7(2):e98-e99. PMID: 35012712.
      View in: PubMed
    27. Flam-Ross JM, Lown J, Patil P, White LF, Wang J, Perry A, Bailer D, McKenzie M, Thigpen A, Newman R, Lincoln M, Mckinney T, Bernson D, Barocas JA. Factors associated with opioid-involved overdose among previously incarcerated people in the U.S.: A community engaged narrative review. Int J Drug Policy. 2022 02; 100:103534. PMID: 34896932.
      View in: PubMed
    28. Barocas JA, Eftekhari Yazdi G, Savinkina A, Nolen S, Savitzky C, Samet JH, Englander H, Linas BP. Long-term Infective Endocarditis Mortality Associated With Injection Opioid Use in the United States: A Modeling Study. Clin Infect Dis. 2021 12 06; 73(11):e3661-e3669. PMID: 32901815.
      View in: PubMed
    29. Barocas JA, Savinkina A, Adams J, Jawa R, Weinstein ZM, Samet JH, Linas BP. Clinical impact, costs, and cost-effectiveness of hospital-based strategies for addressing the US opioid epidemic: a modelling study. Lancet Public Health. 2022 01; 7(1):e56-e64. PMID: 34861189.
      View in: PubMed
    30. Barocas JA, Umar I, Praseuth A, Evans L, Zaller ND, Zielinski MJ. An Economic Analysis of the Cost of a Regional Crisis Stabilization Unit. J Correct Health Care. 2022 02; 28(1):54-58. PMID: 34788552.
      View in: PubMed
    31. Grebely J, Collins AB, Artenie AA, Sutherland R, Meyer JP, Barocas JA, Falade-Nwulia O, Cepeda JA, Cunningham EB, Hajarizadeh B, Lafferty L, Lazarus JV, Bonn M, Marshall AD, Treloar C. Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs. Int J Drug Policy. 2021 10; 96:103469. PMID: 34610884.
      View in: PubMed
    32. Jawa R, Stein MD, Anderson B, Liebschutz JM, Stewart C, Phillips KT, Barocas JA. Behavioral Risk Factors for HIV Infection in Hospitalized Persons Who Co-use Stimulants and Opioids. AIDS Behav. 2022 Apr; 26(4):1047-1055. PMID: 34510289.
      View in: PubMed
    33. King CA, Englander H, Korthuis PT, Barocas JA, McConnell KJ, Morris CD, Cook R. Designing and validating a Markov model for hospital-based addiction consult service impact on 12-month drug and non-drug related mortality. PLoS One. 2021; 16(9):e0256793. PMID: 34506517.
      View in: PubMed
    34. Harris MTH, Young S, Barocas J, Bayoumi AM, Caudarella A, Laurence G, Tomanovich M, Komaromy M. A Descriptive Comparison of Substance Use Services in Recovery and Isolation Sites for People Experiencing Homelessness During the COVID-19 Pandemic, Boston and Toronto. Public Health Rep. 2021 Sep-Oct; 136(5):532-537. PMID: 34269625.
      View in: PubMed
    35. Barocas JA, Earnest M. The Urgent Public Health Need to Develop "Crisis Standards of Housing": Lessons From the COVID-19 Pandemic. Am J Public Health. 2021 07; 111(7):1207-1209. PMID: 34370530.
      View in: PubMed
    36. Morgan JR, Walley AY, Murphy SM, Chatterjee A, Hadland SE, Barocas J, Linas BP, Assoumou SA. Characterizing initiation, use, and discontinuation of extended-release buprenorphine in a nationally representative United States commercially insured cohort. Drug Alcohol Depend. 2021 08 01; 225:108764. PMID: 34051547.
      View in: PubMed
    37. Epstein RL, Sperring H, Hofman M, Lodi S, White LF, Barocas JA, Bouton TC, Xiao Y, Hsu HE, Miller NS, Linas BP, Marathe JG. Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals? Open Forum Infect Dis. 2021 Jun; 8(6):ofab164. PMID: 34189164.
      View in: PubMed
    38. Dunham K, McDonald J, Yousaf A, Barocas JA, Neill M, Noska A, Flanigan TP. Healthcare Providers' Views on Hepatitis C Testing and Counseling Among Sexual Partners of Hepatitis-C-Infected Persons: An Online Survey. Infect Dis Clin Pract (Baltim Md). 2021 May; 29(3):e151-e153. PMID: 34447237.
      View in: PubMed
    39. Barocas JA. It's Not Them, It's Us: Hepatitis C Reinfection Following Successful Treatment Among People Who Inject Drugs. Clin Infect Dis. 2021 04 26; 72(8):1401-1403. PMID: 32166311.
      View in: PubMed
    40. Hadland SE, Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Morgan JR, Barocas JA. Opioid use disorder and overdose among youth following an initial opioid prescription. Addiction. 2021 10; 116(10):2790-2800. PMID: 33739476.
      View in: PubMed
    41. Jawa R, Stein MD, Anderson B, Liebschutz JM, Stewart C, Phillips KT, Barocas JA. Association of skin infections with sharing of injection drug preparation equipment among people who inject drugs. Int J Drug Policy. 2021 08; 94:103198. PMID: 33744668.
      View in: PubMed
    42. Barocas JA, Choo EK. Housing Is an Essential Part of Health Care-"Treat 'Em and House 'Em". JAMA Netw Open. 2021 03 01; 4(3):e210635. PMID: 33651106.
      View in: PubMed
    43. Barocas JA, Gai MJ, White LF, Faretra D, Sachs K, Komaromy M. Implementation of a Recuperation Unit and Hospitalization Rates Among People Experiencing Homelessness With COVID-19. JAMA Netw Open. 2021 03 01; 4(3):e212826. PMID: 33688963.
      View in: PubMed
    44. Barocas JA, Jacobson KR, Hamer DH. Addressing the COVID-19 Pandemic Among Persons Experiencing Homelessness: Steps to Protect a Vulnerable Population. J Gen Intern Med. 2021 05; 36(5):1416-1417. PMID: 33532960.
      View in: PubMed
    45. Linas BP, Savinkina A, Madushani RWMA, Wang J, Eftekhari Yazdi G, Chatterjee A, Walley AY, Morgan JR, Epstein RL, Assoumou SA, Murphy SM, Schackman BR, Chrysanthopoulou SA, White LF, Barocas JA. Projected Estimates of Opioid Mortality After Community-Level Interventions. JAMA Netw Open. 2021 02 01; 4(2):e2037259. PMID: 33587136.
      View in: PubMed
    46. Barocas JA, Morgan JR, Wang J, McLoone D, Wurcel A, Stein MD. Outcomes Associated With Medications for Opioid Use Disorder Among Persons Hospitalized for Infective Endocarditis. Clin Infect Dis. 2021 02 01; 72(3):472-478. PMID: 31960025.
      View in: PubMed
    47. Komaromy M, Harris M, Koenig RM, Tomanovich M, Ruiz-Mercado G, Barocas JA. Caring for COVID's Most Vulnerable Victims: a Safety-Net Hospital Responds. J Gen Intern Med. 2021 04; 36(4):1006-1010. PMID: 33469746.
      View in: PubMed
    48. Barocas JA. Business Not as Usual - Covid-19 Vaccination in Persons with Substance Use Disorders. N Engl J Med. 2021 01 14; 384(2):e6. PMID: 33378604.
      View in: PubMed
    49. Rubin EJ, Baden LR, Barocas JA, Morrissey S. Audio Interview: SARS-CoV-2 Vaccination and Vulnerable Populations. N Engl J Med. 2020 12 10; 383(24):e143. PMID: 33296567.
      View in: PubMed
    50. Bagley SM, Gai MJ, Earlywine JJ, Schoenberger SF, Hadland SE, Barocas JA. Incidence and Characteristics of Nonfatal Opioid Overdose Among Youths Aged 11 to 24 Years by Sex. JAMA Netw Open. 2020 12 01; 3(12):e2030201. PMID: 33331919.
      View in: PubMed
    51. Morgan JR, Barocas JA, Murphy SM, Epstein RL, Stein MD, Schackman BR, Walley AY, Linas BP. Comparison of Rates of Overdose and Hospitalization After Initiation of Medication for Opioid Use Disorder in the Inpatient vs Outpatient Setting. JAMA Netw Open. 2020 12 01; 3(12):e2029676. PMID: 33320266.
      View in: PubMed
    52. Komaromy M, Harris M, Koenig RM, Tomanovich M, Ruiz-Mercado G, Barocas JA. Caring for COVID's most vulnerable victims: a safety-net hospital responds. Res Sq. 2020 Oct 26. PMID: 33140040.
      View in: PubMed
    53. Min JE, Pearce LA, Homayra F, Dale LM, Barocas JA, Irvine MA, Slaunwhite AK, McGowan G, Torban M, Nosyk B. Estimates of opioid use disorder prevalence from a regression-based multi-sample stratified capture-recapture analysis. Drug Alcohol Depend. 2020 12 01; 217:108337. PMID: 33049520.
      View in: PubMed
    54. Aldridge AP, Barbosa C, Barocas JA, Bush JL, Chhatwal J, Harlow KJ, Hyder A, Linas BP, McCollister KE, Morgan JR, Murphy SM, Savitzky C, Schackman BR, Seiber EE, E Starbird L, Villani J, Zarkin GA. Health economic design for cost, cost-effectiveness and simulation analyses in the HEALing Communities Study. Drug Alcohol Depend. 2020 12 01; 217:108336. PMID: 33152672.
      View in: PubMed
    55. Springer SA, Barocas JA, Wurcel A, Nijhawan A, Thakarar K, Lynfield R, Hurley H, Snowden J, Thornton A, Del Rio C. Federal and State Action Needed to End the Infectious Complications of Illicit Drug Use in the United States: IDSA and HIVMA's Advocacy Agenda. J Infect Dis. 2020 09 02; 222(Suppl 5):S230-S238. PMID: 32877568.
      View in: PubMed
    56. Schranz A, Barocas JA. Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments. Infect Dis Clin North Am. 2020 09; 34(3):479-493. PMID: 32782097.
      View in: PubMed
    57. Barocas JA, Blackstone E, Bouton TC, Kimmel SD, Caputo A, Porter SJ, Walley AY. Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA. J Addict Med. 2020 Sep/Oct; 14(5):e261-e263. PMID: 32530889.
      View in: PubMed
    58. Barocas JA, Komaromy M, Haidar D, Barlam TF, Orr BL, Miller NS. Assessment of Oropharyngeal Specimens for Discontinuation of Transmission-Based COVID-19 Precautions. Open Forum Infect Dis. 2020 Sep; 7(9):ofaa382. PMID: 32964067.
      View in: PubMed
    59. Barocas JA. Commentary on Jones et al. (2020): Using indirect estimation methods of drug use prevalence to address racial and ethnic health disparities. Addiction. 2020 12; 115(12):2405-2406. PMID: 32822524.
      View in: PubMed
    60. Kimmel SD, Bazzi AR, Barocas JA. Integrating harm reduction and clinical care: Lessons from Covid-19 respite and recuperation facilities. J Subst Abuse Treat. 2020 11; 118:108103. PMID: 32972644.
      View in: PubMed
    61. Barocas JA, Gai MJ, Amuchi B, Jawa R, Linas BP. Impact of medications for opioid use disorder among persons hospitalized for drug use-associated skin and soft tissue infections. Drug Alcohol Depend. 2020 10 01; 215:108207. PMID: 32795883.
      View in: PubMed
    62. Gaeta JM, De Las Nueces D, Munson DG, Barocas JA, Walsh KE. Case 21-2020: A 66-Year-Old Homeless Man with Covid-19. N Engl J Med. 2020 Jul 09; 383(2):170-178. PMID: 32579806.
      View in: PubMed
    63. Rosenberg ES, Barocas JA. USPSTF's Hepatitis C Screening Recommendation-A Necessary Step to Tackling an Evolving Epidemic. JAMA Netw Open. 2020 03 02; 3(3):e200538. PMID: 32119098.
      View in: PubMed
    64. Serota DP, Barocas JA, Springer SA. Infectious Complications of Addiction: A Call for a New Subspecialty Within Infectious Diseases. Clin Infect Dis. 2020 02 14; 70(5):968-972. PMID: 31420651.
      View in: PubMed
    65. Morgan JR, Wang J, Barocas JA, Jaeger JL, Durham NN, Babakhanlou-Chase H, Bharel M, Walley AY, Linas BP. Opioid overdose and inpatient care for substance use disorder care in Massachusetts. J Subst Abuse Treat. 2020 05; 112:42-48. PMID: 32199545.
      View in: PubMed
    66. Merchant E, Burke D, Shaw L, Tookes H, Patil D, Barocas JA, Wurcel AG. Hospitalization outcomes of people who use drugs: One size does not fit all. J Subst Abuse Treat. 2020 05; 112:23-28. PMID: 32199542.
      View in: PubMed
    67. Barocas JA. Commentary on Irvine et al. (2019): Barriers to implementing a successful roadmap for preventing opioid-related overdose deaths. Addiction. 2019 09; 114(9):1614-1615. PMID: 31321824.
      View in: PubMed
    68. Barocas JA, So-Armah K, Cheng DM, Lioznov D, Baum M, Gallagher K, Fuster D, Gnatienko N, Krupitsky E, Freiberg MS, Samet JH. Zinc deficiency and advanced liver fibrosis among HIV and hepatitis C co-infected anti-retroviral na?ve persons with alcohol use in Russia. PLoS One. 2019; 14(6):e0218852. PMID: 31246992.
      View in: PubMed
    69. Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 10; 72:160-168. PMID: 31085063.
      View in: PubMed
    70. Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, Beckwith CG, Linas BP, Walley AY. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019 07 01; 200:59-63. PMID: 31100636.
      View in: PubMed
    71. Barocas JA. Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics. Ann Intern Med. 2019 04 02; 170(7):509. PMID: 30934073.
      View in: PubMed
    72. Barocas JA, Saitz R. Being Explicit About Decisions: Prescribe Medications for Opioid Use Disorder on the Basis of Proven Effectiveness, Not Beliefs. Ann Intern Med. 2019 01 15; 170(2):127-128. PMID: 30557444.
      View in: PubMed
    73. Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 12; 108(12):1675-1681. PMID: 30359112.
      View in: PubMed
    74. Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 08 01; 67(4):549-556. PMID: 29420742.
      View in: PubMed
    75. Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Aff (Millwood). 2017 12; 36(12):2142-2150. PMID: 29200354.
      View in: PubMed
    76. Barocas JA, Beiser M, Le?n C, Gaeta JM, O'Connell JJ, Linas BP. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017 06 01; 177(6):880-882. PMID: 28395004.
      View in: PubMed
    77. Barocas JA, Linas BP. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis. Clin Infect Dis. 2017 01 01; 64(1):100-101. PMID: 27815292.
      View in: PubMed
    78. Barocas JA, Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Mar; 3(2):ofw075. PMID: 27191007.
      View in: PubMed
    79. Barocas JA, Baker L, Hull SJ, Stokes S, Westergaard RP. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug Alcohol Depend. 2015 Sep 01; 154:283-6. PMID: 26143300.
      View in: PubMed
    80. Barocas JA, Erlandson KM, Belzer BK, Hess T, Sosman J. Advance directives among people living with HIV: room for improvement. AIDS Care. 2015; 27(3):370-7. PMID: 25307722.
      View in: PubMed
    81. Brennan MB, Barocas JA, Crnich CJ, Hess TM, Kolehmainen CJ, Sosman JM, Sethi AK. "Oops! I forgot HIV": resident physician self-audits and universal HIV screening. J Infect Public Health. 2015 Mar-Apr; 8(2):161-9. PMID: 25277258.
      View in: PubMed
    82. Barocas JA, Gauthier GM. Peritonitis caused by Blastomyces dermatitidis in a kidney transplant recipient: case report and literature review. Transpl Infect Dis. 2014 Aug; 16(4):634-41. PMID: 24862205.
      View in: PubMed
    83. Barocas JA, Brennan MB, Hull SJ, Stokes S, Fangman JJ, Westergaard RP. Barriers and facilitators of hepatitis C screening among people who inject drugs: a multi-city, mixed-methods study. Harm Reduct J. 2014 Jan 14; 11:1. PMID: 24422784.
      View in: PubMed
    84. Brennan MB, Kolehmainen C, Barocas J, Isaac C, Crnich CJ, Sosman JM. Barriers and facilitators of universal HIV screening among internal medicine residents. WMJ. 2013 Oct; 112(5):199-205. PMID: 24734414.
      View in: PubMed
    85. Bauer CL, Victorson D, Rosenbloom S, Barocas J, Silver RK. Alleviating distress during antepartum hospitalization: a randomized controlled trial of music and recreation therapy. J Womens Health (Larchmt). 2010 Mar; 19(3):523-31. PMID: 20141383.
      View in: PubMed
    86. Barocas J, Mittal A, Borum ML. Colon cancer screening consultations can aid in obesity management. Obesity (Silver Spring). 2009 Jun; 17(6):1112. PMID: 19584875.
      View in: PubMed
    87. Victorson D, Barocas J, Song J, Cella D. Reliability across studies from the functional assessment of cancer therapy-general (FACT-G) and its subscales: a reliability generalization. Qual Life Res. 2008 Nov; 17(9):1137-46. PMID: 18841493.
      View in: PubMed
    88. Lai JS, Cella D, Peterman A, Barocas J, Goldman S. Anorexia/cachexia-related quality of life for children with cancer. Cancer. 2005 Oct 01; 104(7):1531-9. PMID: 16088963.
      View in: PubMed
    Barocas's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (256) concept(s)
    _
    Co-Authors Expand Description
    See all (4) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)